These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2470188)

  • 21. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.
    Mani S; Todd MB; Katz K; Poo WJ
    J Urol; 1995 Jul; 154(1):35-40. PubMed ID: 7539867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intra-arterial chemotherapy in urological cancer].
    Mitsumori K; Sato K; Kato T
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):197-203. PubMed ID: 11865624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.
    Negrier S; Maral J; Drevon M; Vinke J; Escudier B; Philip T
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S93-8. PubMed ID: 10685667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma].
    Atzpodien J; Kirchner H; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():38-43. PubMed ID: 8692118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
    Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
    Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential role for metformin in urologic oncology.
    Sayyid RK; Fleshner NE
    Investig Clin Urol; 2016 May; 57(3):157-64. PubMed ID: 27195314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multidisciplinary therapy of urogenital cancer].
    Matsumura Y
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1165-9. PubMed ID: 4057573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of immunotherapy in urologic malignancies.
    Abubakr YA; Redman BG
    Cancer Treat Res; 1996; 88():235-48. PubMed ID: 9239484
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immune parameters of peripheral blood in chemoembolization with microencapsulated anticancer drugs].
    Sato K; Abe R; Moriyama M; Kato T; Tsuchida S
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):73-7. PubMed ID: 2783546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of immunotherapy for urological tumours.
    Hrouda D; Muir GH; Dalgleish AG
    Br J Urol; 1997 Mar; 79(3):307-16. PubMed ID: 9117206
    [No Abstract]   [Full Text] [Related]  

  • 31. Genitourinary malignancy.
    Hudes GR; Ozols RF; Giantonio B
    Cancer Chemother Biol Response Modif; 1994; 15():531-54. PubMed ID: 7779598
    [No Abstract]   [Full Text] [Related]  

  • 32. [New therapies for urologic cancer diseases. The Danish Society of Urology].
    Lund L; Borre M; Hermann GG; Svolgaard N;
    Ugeskr Laeger; 2008 Mar; 170(12):1057. PubMed ID: 18397675
    [No Abstract]   [Full Text] [Related]  

  • 33. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What's new in urology.
    Williams RD
    J Am Coll Surg; 2002 Nov; 195(5):663-74. PubMed ID: 12437254
    [No Abstract]   [Full Text] [Related]  

  • 35. Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.
    Figlin R; Gitlitz B; Franklin J; Dorey F; Moldawer N; Rausch J; deKernion J; Belldegrun A
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S92-7. PubMed ID: 9457402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of renal cell carcinoma].
    Yamada Y; Fukatsu H; Honda N; Miyagawa Y; Segawa A
    Hinyokika Kiyo; 1993 Dec; 39(12):1197-203. PubMed ID: 7506869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urologic oncology].
    Meran JG; Schramek P
    Wien Med Wochenschr; 2011 Aug; 161(15-16):365. PubMed ID: 21953424
    [No Abstract]   [Full Text] [Related]  

  • 38. Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients.
    Marten-Perolino R; Cocimano V; Botto A; Buffa G; Riggi E; Trapani C
    J Exp Pathol; 1987; 3(4):587-92. PubMed ID: 3454806
    [No Abstract]   [Full Text] [Related]  

  • 39. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1987; 9():280-302. PubMed ID: 2856337
    [No Abstract]   [Full Text] [Related]  

  • 40. Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma.
    Quesada JR; Evans L; Saks SR; Gutterman JU
    J Biol Response Mod; 1988 Jun; 7(3):234-9. PubMed ID: 3134511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.